Migraine Clinical Trials in Houston

Showing 61-80 of 93 trials

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

NCT04089761

Nerivio™ is an FDA-authorized remote electrical neuromodulation (REN) device for the acute treatment of migraine with or without aura in patients 18 years old or above who do not have chronic migraine. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. This is a prospective, single arm, open label, multicenter trial of the safety and efficacy of Nerivio™ for the acute treatment of migraine in adolescents The study will be conducted in three phases: Phase I - Run-in: Phase II - Treatment phase: Phase III (optional) - Free-use

Acute Migraine

Theranica60 participantsStarted Oct 2019

Aurora, Colorado, United States • Hialeah, Florida, United States • Miami, Florida, United States +9 more locations

WITHDRAWNPhase 2/3< 1 mile

Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH)

NCT00373074

The purpose of this study is to address the question, "What is the volume of blood for injection at epidural blood patch that most effectively relieves post-dural puncture headache?"

Post-Lumbar Puncture Headache

The University of Texas Health Science Center, HoustonStarted Sep 2006

Houston, Texas, United States

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH)

Migraine Trials in Other Cities

PREMIUM Migraine Trial

Study in Participants With Acute Migraines Headaches

ESCAPE Migraine Trial

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Zomig - Treatment of Acute Migraine Headache in Adolescents

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

MLD10 in the Prevention of Migraine in Adults

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Other Conditions in Houston